VT

Vishwa Teja Tukuntla

Active Director Director DIN 10182474
DIN 10182474 First appointment Oct 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishwa Teja Tukuntla

Data last updated:

Vishwa Teja Tukuntla is a Director at Indur Institute Of Medical Sciences Private Limited (since 2023). The company operates in Healthcare.

DIN 10182474
Primary Designation Director
Industry Healthcare
First Appointment 23 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20232022Active

Directorship timeline

Open interactive timeline →
Indur Institute Of Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Vishwa Teja Tukuntla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishwa Teja Tukuntla

Vishwa Teja Tukuntla currently holds 1 directorship: Indur Institute Of Medical Sciences Private Limited (Director, since 23 Oct 2023).

Vishwa Teja Tukuntla was first appointed on 23 Oct 2023 as Director at Indur Institute Of Medical Sciences Private Limited.

The current boards of Vishwa Teja Tukuntla's companies include Anvesh Krishna Medi (Indur Institute Of Medical Sciences Private Limited), Harsha Vardhan Goud Bushanam (Indur Institute Of Medical Sciences Private Limited), Megharaj Kesha (Indur Institute Of Medical Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available